Sign inGet started

Palani Santhosh

Insider CIK 2013475 · ACRV Director · PYXS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ACRV Acrivon Therapeutics, Inc. A Award deriv2026-06-172026-06-2220,275— $020,275SEC↗
ACRV Acrivon Therapeutics, Inc. A Award2026-05-182026-05-209,366— $09,366SEC↗
PYXS Pyxis Oncology, Inc. A Award deriv2026-03-242026-03-2545,867— $045,867SEC↗
ACRV Acrivon Therapeutics, Inc. A Award deriv2025-06-132025-06-1720,275— $020,275SEC↗
PYXS Pyxis Oncology, Inc. A Award deriv2025-03-312025-04-0236,979$0.98 $36.2K36,979SEC↗
PYXS Pyxis Oncology, Inc. A Award2024-06-072024-06-076,000— $06,000SEC↗
PYXS Pyxis Oncology, Inc. A Award deriv2024-03-122024-03-1369,760— $069,760SEC↗
ACRV Acrivon Therapeutics, Inc. A Award deriv2024-03-042024-03-0632,500— $032,500SEC↗